|Clal Biotechnology Industries Ltd -- Israel Stock|| |
ILS 368 364.33 9,927%
VP and General Counsel
We currently do not have informatin regarding Orit Lidor. This executive tanure with Clal Biotechnology Industries Ltd is not currenlty determined.
Age: 35 VP Since 2011
972 3 612 1616 http://www.cbi.co.il
The company has return on total asset (ROA)
of (4.67) %
which means that it has lost $4.67 on every $100 spent on asset. This is way below average. Similarly, it shows return on equity (ROE)
of (26.55) %
meaning that it generated substantial loss on money invested by shareholders.
The company has accumulated 77.26 M in total debt with debt to equity ratio (D/E) of 9.1 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Clal Biotechnology Industries Ltd has Current Ratio of 4.64 suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due.
Clal Biotechnology Industries Ltd. is a private equity and VC firm specializing in development stage, preclinical; incubation, seed, startup, early venture, emerging growth, mid venture, late venture, PIPEs, and growth capital stages of financing. Clal Biotechnology Industries Ltd (CBI) is traded on Tel Aviv Stock Exchange in Israel. It is located in Tel Aviv, and employs 14 people.